-
What Do Versartis' Troubles Mean For Opko Health?
Friday, September 22, 2017 - 11:26am | 597Read More...Versartis Inc (NASDAQ: VSAR) shares are slumping even as rival Opko Health Inc. (NASDAQ: OPK) is seeing slight strength, though not proportionate to the sell-off seen in Versartis shares. News Behind The Move Versartis announced Thursday after the market close that its Somavaratan, a long-...
-
Opko Health's 18% Selloff Offers Buying Opportunity
Tuesday, January 3, 2017 - 9:12am | 303Read More...Shares of Opko Health Inc. (NASDAQ: OPK) slumped after the release of mixed results from a Phase III clinical study of long-acting human growth hormone [hGH-CTP] candidate in adults with growth hormone deficiency. “We view the sell off as overblown and an opportunity to acquire shares,...
-
Ladenburg Initiates BioTime Shares With Buy, $6 Price Target
Friday, September 23, 2016 - 8:59am | 306Read More...BioTime, Inc. (NYSEMKT: BTX) is in the midst of a restructuring that is aimed at unlocking shareholder value by separating non-core assets and the accelerated development of cell therapy programs in ophthalmetry, aesthetics and orthopedics, Ladenburg’s Kevin DeGeeter said in a report. He...
-
Ladenburg Says No Need For Novavax To Rerun Failed Drug Study
Friday, September 16, 2016 - 8:57am | 338Read More...Top-line Phase III data for Novavax, Inc’s (NASDAQ: NVAX) RSV F nanoparticle vaccine for the prevention of RSV in the elderly was disappointing, Ladenburg’s Kevin DeGeeter said in a report. He downgraded the rating on the company from Buy to Neutral, and removed the price target....
-
Ladenburg Downgrades Progress Software, Cites Valuation
Tuesday, September 13, 2016 - 9:39am | 301Read More...Shares of Progress Software Corporation (NASDAQ: PRGS) have gained 17 percent since March 14, 2016. Ladenburg’s Glenn G. Mattson downgraded the rating on the company from Buy to Neutral, citing valuation. He added that so far the Telerik acquisition had been disappointing. Progress...
-
Ladenburg Raises Taser's Price Target To $31, Cheers Videos Shipments
Friday, August 5, 2016 - 7:21am | 354Read More...TASER International, Inc. (NASDAQ: TASR) reported strong 2Q16 results, and has a “significant potential growth driver,” Ladenburg’s Glenn G. Mattson said in a report. He reiterated a Buy rating on the company, while raising the price target from $28 to $31. Taser reported...
-
Ladenburg Analysts Are Bullish On DCP Midstream, Waiting For Future Catalysts To Find An Entry Point
Thursday, July 21, 2016 - 9:39am | 308Read More...DCP Midstream Partners, LP (NYSE: DPM) is positioned strategically to benefit from a market recovery, Ladenburg’s Richard A. Verdi said in a report. He reinitiated coverage of the company with a Neutral rating and a price target of $36, saying that the stock appears fairly valued “...
-
Hotel REIT Sector Downgraded To Sell At Ladenburg
Tuesday, January 19, 2016 - 3:24pm | 271Read More...Ladenberg Thalman analyst Daniel Donlan has finally pulled the trigger on a downgrade of hotel REITs this week. According to Donlan, investors should now be selling hotel REITs because they face too many potential headwinds in 2016. “With many economists having recently lowered their 4Q...
-
Ladenburg Analyst: Taser's Attractive Valuation Can't Be Ignored Anymore, Worth $24/Share
Wednesday, November 18, 2015 - 10:27am | 357Read More...TASER International, Inc. (NASDAQ: TASR) shares are down 37 percent year-to-date, and are trading significantly below their 52-week high of $35.95. Ladenburg’s Glenn G. Mattson upgraded the rating on the company from Neutral to Buy, while establishing a price target of $24....
-
Sequenom Can't Go Back; Ladenburg Analysts Downgrade To Sell
Tuesday, September 29, 2015 - 4:29pm | 396Read More...Shares of Sequenom, Inc. (NASDAQ: SQNM) are down roughly 13 percent on Tuesday trading, following the company's investor day event on Monday. Following the gathering, analysts at Ladenburg Thalmann downgraded shares of the company from Neutral to Sell, setting a $0.90 price target. According to a...
-
Ladenburg: 'Not Enough Upside' For Taser
Monday, December 8, 2014 - 5:08pm | 302Read More...Taser International, Inc. (NASDAQ: TASR), faced with explosive demand from law enforcement for its body mounted cameras, could face a keystone cops scenario that poses risks to smooth growth. "Many of these agencies have antiquated systems," Ladenburg's Glenn G. Mattson said in a...
-
Ladenburg Opens NLY With Buy
Tuesday, February 1, 2011 - 8:14am | 49Read More...Analysts at Ladenburg initiate coverage of Annaly Capital Management Inc (NYSE: NLY) with a “buy” rating. The target price for NLY is set to $19. NLY shares closed at $17.83 yesterday. More Analyst Ratings here
-
Ladenburg Initiates CXS With Buy
Tuesday, February 1, 2011 - 7:57am | 50Read More...Analysts at Ladenburg initiate coverage of Crexus Investment Corp (NYSE: CXS) with a “buy” rating. The target price for CXS is set to $15. CXS shares gained 0.98% to close at $13.41 yesterday. More Analyst Ratings here
-
XNPT Downgraded At Ladenburg
Thursday, February 18, 2010 - 12:54pm | 39Read More...Analysts at Ladenburg downgrade XenoPort (NASDAQ: XNPT) from "buy" to "sell." XNPT’s shares plunged 65.42% to reach $6.78 at 10:39 am. More Analyst Ratings here
-
El Paso Pipeline Partners Upgraded To Buy
Friday, February 5, 2010 - 11:43am | 47Read More...Analysts at Ladenburg upgrade El Paso Pipeline Partners LP (NYSE: EPB) from "neutral" to "buy." Ladenburg finds ERB's valuation attractive. EPB’s shares closed at $23.60 yesterday. Read more about the market
